NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Reckitt Benckiser Pharmaceuticals


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Analgesics - Global Strategic Business Report Profiles 139 Companies Including Many Key and Niche Players
2009 MAR 23 ... Johnson & Johnson, McNeil Consumer Healthcare, Novartis International AG, Pfizer, Inc., Reckitt Benckiser Group Plc, W. F. Young, Inc., Wyeth, and Wyeth Consumer Healthcare. Market ... Analgesics, Acetaminophen, Analgesia, Aspirin, Drugs, Ibuprofen, Pain Medicine, Pharmaceuticals, Therapy, Treatment, Research and Markets. This article was prepared by ...
Subject: Research and Markets
Price: $3.00
*
Examine the Antiseptics and Disinfectants World Market
2009 MAR 23 ... PROFESSIONAL DISPOSABLES INTERNATIONAL PURE BIOSCIENCES RECKITT BENCKISER SAFETEC OF AMERICA SANIVAX TECHNOLOGIES ... Keywords: Behavior, Biopharmaceuticals, Business, Drugs, Patents Actions, Pharmaceuticals, Therapies, ReportLinker. This article was prepared by Biotech Business ...
Subject: ReportLinker
Price: $3.00
*
FDA Accepts Tris Pharma's ANDA with Paragraph IV Certification for a Generic Equivalent to Delsym
2009 JUL 27 ... product prior to the expiration of a patent listed in the FDA's orange book for Reckitt Benckiser's Delsym product. Delsym, a leading OTC brand and the only FDA approved ... Drug Development, Drugs, Excitatory Amino Acid Antagonist, FDA, Generics, Patents, Pharmaceuticals, Regulatory Actions, Therapy, Treatment, U.S. Food and Drug Administration, Tris Pharma. ...
Subject: Generics
Price: $3.00
*
Gary Wenzel Named President TBWAWorldHealth
2009 NOV 23 ... created award winning communications for Novartis Vaccines, Bayer Women's Health, and Reckitt-Benckiser Inc. While at Saatchi Healthcare, Steve re-launched Prilosec, ... and Licensing Agreements, Pfizer, Pharmaceutical Business, Pharmaceutical Company, Pharmaceuticals, Schering-Plough Corporation, Therapy, Treatment, TBWA Worldwide. This ...
Subject: Marketing and Licensing Agreements
Price: $3.00
*
Here to Help(TM): Unique Program Combines Direct Personal Assistance With Web-Based Resources to Improve Opioid Dependence Treatment Outcomes
2009 JUN 1 ... Reckitt Benckiser Pharmaceuticals has launched Here to Help(TM), an unique patient support program designed to improve ...
Subject: Opioid Dependence
Price: $3.00
*
Key Challenges and Issues Facing the U.S. Markets for Addiction and Substance Abuse Treatment
2009 MAR 23 ... INDUSTRY STRUCTURE MARKET LEADERS PFIZER RECKITT BENCKISER GLAXOSMITHKLINE NOVARTIS ... of the evolving nature of this important area of medicine, executives of substance abuse pharmaceuticals must remain ever vigilant to the changing environment and strive to keep abreast of new ...
Subject: ReportLinker
Price: $3.00
*
Medicated Skin Care Products - Global Strategic Business Report
2009 MAR 31 ... Neutrogena Corp, Novartis AG, Obagi Medical Products, Inc., Procter & Gamble Company, Reckitt Benckiser Plc., Rohto Pharmaceutical, Mentholatum Co., Inc., Stiefel Laboratories, ... Keywords: Research and Markets, Pharmaceuticals. This article was prepared by Drug Law Weekly editors from staff and ...
Subject: Research and Markets
Price: $3.00
*
New dentistry research from S. Daniels et al outlined
2009 APR 20 ... 2009;65(4):343-353). For more information, contact P. Berry, Reckitt Benckiser Healthcare UK, Dansom Lane, Kingston Upon Hull HU8 7DS, N Humberside, UK. ... Pharmacology, Dentistry, Drugs, Ibuprofen, Oral Health, Pain Management, Pain Medicine, Pharmaceuticals, Pharmacology, Post-operative Pain, Therapies, Therapy, Treatment. This ...
Subject: Dentistry
Price: $3.00
*
Watson Files FDA Application for Generic Mucinex(R) D
2009 JUN 22 ... 600mg/60mg and 1200mg/120mg tablets prior to the expiration of patents owned by Reckitt Benckiser Inc. Watson Laboratories, Inc. - Florida's guaifenesin pseudoephedrine HCI ... Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading specialty pharmaceutical company, confirmed that its ...
Subject: Generics
Price: $3.00
*
Watson Files FDA Applications for Generic Mucinex(R)
2009 MAY 4 ... 30mg/600mg and 60mg/1200mg tablets prior to the expiration of patents owned by Reckitt Benckiser Inc. Watson's guaifenesin and dextromethorphan HBr/guaifenesin ... Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading specialty pharmaceutical company, confirmed that it has ...
Subject: Generics
Price: $3.00
*
Xanodyne Announces New President/CEO and Completes $38 Million Equity Financing
2009 JUN 15 ... Health Care IPO in 2005. In January 2008, he successfully led the sale of the company to Reckitt Benckiser for $2.3B. Mr. Valentino said, "I look forward to working ... Xanodyne Pharmaceuticals, Inc. is pleased to announce that Michael J. Valentino has been named to the position of ...
Subject: Pharmaceuticals
Price: $3.00
*
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM)
2008 JUL 14 ... in annual revenue. Mr. Thievon left Adams in February 2008, following its acquisition by Reckitt Benckiser. Mr. Becker was also a former senior executive at Adams, where ... MiddleBrook Pharmaceuticals, Inc. (NASDAQ:MBRK), a pharmaceutical company focused on developing and commercializing ...
Subject: MiddleBrook Pharmaceuticals, Inc.
Price: $3.00
*
MWV Reports Third Quarter 2008 Results
2008 NOV 11 ... the global home and garden products industry. Major customers of Continental AFA include Reckitt Benckiser, Church & Dwight and Clorox. Consumer & Office Products ... please visit www.mwv.com. Keywords: MeadWestvaco Corporation, Pharmaceuticals. This article was prepared by Drug Law Weekly editors from staff and ...
Subject: MeadWestvaco Corporation
Price: $3.00
*
Publicis Selling Solutions Launches New SFA Sidekick(TM), a Web-Based Collaborative Contact Management Tool
2008 FEB 4 ... while providing online reports to support the decision making process." Reckitt Benckiser Pharmaceuticals, a client of Publicis Selling Solutions, is using the SFA Sidekick(TM) target management ...
Subject: Publicis Selling Solutions
Price: $3.00
*
Research and Markets: In November 2007, the NHS in the United Kingdom Announced That a Budget Undershoot for 2007/2008 of GBP1.8bn (US$3.72bn) Was Expected
2008 MAR 17 ... considered one of the weaker areas in GSK's portfolio. Meanwhile, consumer goods firm Reckitt Benckiser has increased its presence in the OTC sector with the purchase of US company ... has announced the addition of United Kingdom Pharmaceuticals & Healthcare Report Q1 2008 to their offering. The United Kingdom ...
Subject: Research and Markets Ltd.
Price: $3.00
*
Schering-Plough Appoints Janet M. Barth Vice President, Investor Relations
2008 JUN 9 ... and corporate communications programs for the company prior to its acquisition by Reckitt Benckiser in January 2008. Previously, Barth was employed for 14 years by ... Corporation, Pharmaceutical Business, Pharmaceutical Company, Therapy, Treatment, Pharmaceuticals. This article was prepared by Biotech Business Week editors from staff ...
Subject: Schering-Plough Corporation
Price: $3.00
*
SMARTANALYST, Inc. Managing Director, Marc Rovner to Appear as Featured Speaker at Global OTC Conference
2008 APR 21 ... Banner Pharamacaps, Johnson & Johnson, Europe, Ladybird Cottage, Merck CHC France and Reckitt Benckiser. The conference runs from April 9th - 11th, 2008. Keywords: ... runs from April 9th - 11th, 2008. Keywords: SMARTANALYST, Inc., Pharmaceuticals This article was prepared by Pharma Business Week editors from staff and ...
Subject: SMARTANALYST, Inc.
Price: $3.00
*
United States Pharmaceuticals and Healthcare Report Q2 2008 is out Now
2008 APR 21 ... been snapped up with OTC firm Adams Respiratory Therapeutics being bought by UK-based Reckitt Benckiser. Japanese drugmaker Astellas has also acquired US-based biotech firm Agensys ... has announced the addition of "United States Pharmaceuticals and Healthcare Report Q2 2008" to their offering. The United States ...
Subject: Research and Markets
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login